Treatment resistant depression incidence and prevalence using the French nationwide claims database-Reference-Cited by-同舟云学术

Treatment resistant depression incidence and prevalence using the French nationwide claims database

Published:2020-08-06 Issue:2 Volume:30 Page:169-177
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Bosco‐Lévy Pauline¹^ORCID,Grelaud Angela¹,Blin Patrick¹,Astruc Bernard²,Falissard Bruno³,Llorca Pierre‐Michel⁴⁵,Bernard Marie‐Agnès¹,Lassalle Régis¹,Moore Nicholas¹^ORCID,Droz‐Perroteau Cécile¹

Affiliation:

1. Bordeaux PharmacoEpi, INSERM CIC1401 Université de Bordeaux Bordeaux France

2. Psychiatrist Paris Paris France

3. Centre de Recherche en Épidémiologie et Santé des Populations, INSERM U1018 Maison de Solenn Paris France

4. CMP B CHU Université Clermont Auvergne Clermont‐Ferrand France

5. Fondation FondaMental Créteil France

Funder

JANSSEN France

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pds.5082

Reference27 articles.

1. World Health Organization.Depression and other common mental disorders: global health estimates. 2017.http://apps.who.int/iris/bitstream/10665/254610/1/WHO-MSD-MER-2017.2-eng.pdf?ua=1. Accessed May 19 2017.

2. La dépression en France: évolution de la prévalence, du recours au soin et du sentiment d'information de la population par rapport à;François B;Sante Homme,2005

3. Estimating the prevalence of depression associated with healthcare use in France using administrative databases

4. Cost-of-illness studies of depression

5. Suicidal Behaviour in Mood Disorders—Who, When, and Why?

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment patterns for patients with treatment resistant depression in France using nationwide claims database;2024-01-20

2. The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review;Pharmaceutics;2023-12-13

3. Esketamine nasal spray in patients with treatment-resistant depression: the real-world experience in the French cohort early-access programme;International Journal of Psychiatry in Clinical Practice;2022-02-17

4. Deep Brain Stimulation for Treatment-Resistant Depression;Neuromethods;2022

5. Economic impact of treatment-resistant depression: A retrospective observational study;Journal of Affective Disorders;2021-12